I'm not sure why you think the article is "garbage"?
He does say quite explicitly that there is not necessarily any link that can be drawn between the 7.9months PFS extension, and an OS extension. That can only be demonstrated in a clinical trial, which as we know is currently underway. I read the article as being a warning not to extrapolate OS based on the liver-only PFS results.
SRX Price at posting:
$29.04 Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
